| 1 |
30106444 | Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells. | 2018 Oct |
2 |
| 2 |
22211244 | Lipid metabolic pathways as lung cancer therapeutic targets: a computational study. | 2012 Apr |
3 |
| 3 |
20838437 | Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. | 2010 Sep 3 |
2 |
| 4 |
16857822 | Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway. | 2006 Jul 15 |
3 |
| 5 |
15788691 | Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. | 2005 Mar 15 |
7 |
| 6 |
12942316 | Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells. | 2003 Nov |
1 |